上海罗氏制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Levodopa and Benserazide Hydrochloride Tablets
- Product Name
- 美多芭
- Approval Number
- 国药准字H10930198
- Approval Date
- Jul 2, 2024
NMPA
Mycophenolate Mofetil Capsules
- Product Name
- 骁悉
- Approval Number
- 国药准字H20031240
- Approval Date
- May 7, 2024
NMPA
Ceftriaxone Sodium for Injection
- Product Name
- 罗氏芬
- Approval Number
- 国药准字H10983038
- Approval Date
- May 7, 2024
NMPA
Ceftriaxone Sodium for Injection
- Product Name
- 罗氏芬
- Approval Number
- 国药准字H10983037
- Approval Date
- May 7, 2024
NMPA
Ceftriaxone Sodium for Injection
- Product Name
- 罗氏芬
- Approval Number
- 国药准字H10983036
- Approval Date
- May 7, 2024
NMPA
Mycophenolate Mofetil Tablets
- Product Name
- 骁悉
- Approval Number
- 国药准字H20031277
- Approval Date
- Oct 23, 2019
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found